After several years of faltering progress on the release of new regulatory texts, subsequent delays and rethinks, Vietnam has finally issued a decree on regulating the medtech sector that has met with industry’s approval – to large extent, at least.
Profit And Price Declaration Requirements Mar Otherwise Workable Vietnam Medtech Regulation
Vietnam’s medtech industry breathed more easily when the new decree, 98/2021, became the regulatory instrument for the sector on 1 January. While its practical approach to industry’s needs was welcomed, new price and profit declaration demands will be harder for companies to swallow.
